Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
DW-4301 by Daewon Pharmaceutical for Hyperlipidemia: Likelihood of Approval
DW-4301 is under clinical development by Daewon Pharmaceutical and currently in Phase I for Hyperlipidemia. According to GlobalData, Phase I...
DW-4301 by Daewon Pharmaceutical for Dyslipidemia: Likelihood of Approval
DW-4301 is under clinical development by Daewon Pharmaceutical and currently in Phase II for Dyslipidemia. According to GlobalData, Phase II...
DW-4301 by Daewon Pharmaceutical for Hypercholesterolemia: Likelihood of Approval
DW-4301 is under clinical development by Daewon Pharmaceutical and currently in Phase II for Hypercholesterolemia. According to GlobalData, Phase II...